The manager <a href="http://www.aiq.com.mx/buy/index.php/ashleytreatmentorg-15ab.pdf">cacmeds.com</a> The sale would open a door for pharmaceutical firms to expand into the growing market for biosimilar drugs. But banking industry sources have said would-be bidders are put off by mistrust of management and share price volatility.